tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Genpact’s Strong Financial Performance and Strategic Advancements Drive Buy Rating

Genpact’s Strong Financial Performance and Strategic Advancements Drive Buy Rating

William Blair analyst Maggie Nolan has maintained their bullish stance on G stock, giving a Buy rating today.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Maggie Nolan has given her Buy rating due to a combination of factors that highlight Genpact’s strong financial performance and strategic advancements. The company reported second-quarter results that surpassed management’s guidance for revenue, gross margin, and adjusted EPS, leading to an upward revision of its full-year 2025 outlook. This positive performance was driven by significant growth in Advanced Technology Solutions (ATS) and Core Business Services, with data and AI solutions contributing to a 17% year-over-year increase in ATS.
Additionally, Genpact’s management has shown confidence in achieving its revised targets, with only a modest increase in revenue needed to meet the outlook. The expansion of the Data & AI pipeline and the launch of the AI ‘Gigafactory’ across all verticals further bolster Genpact’s capability to scale AI solutions for clients. The company’s ATS division also demonstrates higher revenue per headcount, enhancing visibility and revenue stability. These factors, along with a strong growth in partnership-related revenue, underpin Nolan’s positive outlook and Buy rating for Genpact.

In another report released today, Needham also maintained a Buy rating on the stock with a $53.00 price target.

Based on the recent corporate insider activity of 50 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of G in relation to earlier this year.

Disclaimer & DisclosureReport an Issue

1